Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.

European urology - 1 Jan 2010

Birkhahn Marc, Mitra Anirban P, Williams Anthony J, Lam Gitte, Ye Wei, Datar Ram H, Balic Marija, Groshen Susan, Steven Kenneth E, Cote Richard J

Abstract excerpt

BACKGROUND: Currently, tumor grade is the best predictor of outcome at first presentation of noninvasive papillary (Ta) bladder cancer. However, reliable predictors of Ta tumor recurrence and progression for individual patients, which could optimize treatment and follow-up schedules based on specific tumor biology, are yet to be identified. OBJECTIVE: To identify genes predictive for recurrence and progression in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Carcinoma in Situ

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Invasiveness

Share to Neoplasm Staging

Share to Predictive Value of Tests

Share to Recurrence

Share to Sensitivity and Specificity

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 19762144
DOI: 10.1016/j.eururo.2009.09.013
PMCID: PMC2828516

Genes

HRAS
CCND3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.PMID 19762144Read ↗

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerSemantic proximity Read ↗

Development of a Multiplex Quantitative PCR Signature to Predict Progression in Non–Muscle-Invasive Bladder CancerSemantic proximity Read ↗

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancerSemantic proximity Read ↗

A New Marker for Prediction of Recurrence in Low-Risk Bladder Cancer: Retrospective Study of ELF-3 and TSC-1Semantic proximity Read ↗

Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder CancerSemantic proximity Read ↗

Bladder Cancer Outcome and Subtype Classification by Gene ExpressionSemantic proximity Read ↗

Identification of a nine‐gene panel as a prognostic indicator for recurrence with muscle‐invasive bladder cancerSemantic proximity Read ↗

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerSemantic proximity Read ↗

Biological determinants of bladder cancer gene expression subtypesSemantic proximity Read ↗

Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target IdentificationSemantic proximity Read ↗

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinomaSemantic proximity Read ↗

A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical OutcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.